Cytokinetics
CYTK
$36.16
Share price
-1.15%
Change (1 day)
-32.32%
Change (1 year)
Categories
Revenue for Cytokinetics (CYTK)
Revenue in 2025 (TTM): $19.21 Million USD
According to Cytokinetics
's latest financial reports the company's current revenue (TTM 
) is $19.21 Million USD. In 2024 the company made a revenue of $18.47 Million USD an increase over the revenue in the year 2023 that were of $7.53 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cytokinetics from 2003 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $19.21 M | 4.03% |
| 2024 | $18.47 M | 145.34% |
| 2023 | $7.53 M | -92.04% |
| 2022 | $94.58 M | 34.3% |
| 2021 | $70.42 M | 26.15% |
| 2020 | $55.82 M | 107.79% |
| 2019 | $26.86 M | -14.71% |
| 2018 | $31.5 M | 135.64% |
| 2017 | $13.36 M | -87.44% |
| 2016 | $0.10 B | 271.3% |
| 2015 | $28.65 M | -38.95% |
| 2014 | $46.94 M | 53.16% |
| 2013 | $30.64 M | 305.45% |
| 2012 | $7.55 M | 88.98% |
| 2011 | $4 M | 55.28% |
| 2010 | $2.57 M | -96.84% |
| 2009 | $81.53 M | 556.5% |
| 2008 | $12.42 M | -8.82% |
| 2007 | $13.62 M | 335.63% |
| 2006 | $3.12 M | -64.91% |
| 2005 | $8.91 M | -33.7% |
| 2004 | $13.44 M | 26.92% |
| 2003 | $10.59 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $0.18 B | 844.36% | 🇺🇸 USA |
 Trevena TRVN | $0.54 M | -97.16% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.11 B | 501.85% | 🇺🇸 USA |
 Amgen AMGN | $34.12 B | 177,473.11% | 🇺🇸 USA |
 Array Technologies ARRY | $1.06 B | 5,440.47% | 🇺🇸 USA |